AI assistant
DEXCOM INC — Director's Dealing 2016
Sep 13, 2016
30198_dirs_2016-09-13_55d5f497-cac9-4845-a0a9-337a954d2ba7.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: DEXCOM INC (DXCM)
CIK: 0001093557
Period of Report: 2016-09-09
Reporting Person: SKYLER JAY S (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2016-09-09 | Common Stock | S | 25000.0 | $94.0715 | Disposed | 17246 | Indirect |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 5011 | Direct |
| Common Stock | 10000 | Indirect |
| Common Stock | 10000 | Indirect |
Footnotes
F1: This transaction was executed in multiple trades at prices ranging from $93.68 to $95.04. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
F2: Shares are held by Skyler Bach Family Limited Partnership, LLP, with respect to which the reporting person is a managing partner of the partnership and maintains voting rights of these shares.
F3: Shares are held by Jennifer Skyler Living Trust, with respect to which the Reporting Person is a trustee.
F4: The reporting person disclaims beneficial ownership of these securities and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose.